Booking Holdings has now shed 22% over the past month to $164.22, yet short sellers have barely added to positions and the analyst community is piling in with fresh coverage — the gap between the stock's performance and the Street's conviction is widening rather than closing.
The short interest picture has shifted marginally since last week's note. The gross short position edged up 0.7% on the week to 63.1% of free float — a reversal from the prior week's reduction, though not a dramatic one. The month-on-month trend still shows a 12% drawdown in short shares, meaning the directional bias in the lending market remains one of shorts gradually stepping back. Borrow conditions back that reading. Cost to borrow has ticked up 20% on the week to 0.49%, but that remains historically low and well within easy-borrow territory. Availability is effectively unlimited — over 9,800% of short interest, meaning the lending pool is not under any meaningful pressure. Options are equally calm. The put/call ratio has actually dipped to 0.86, fractionally below its 20-day average of 0.87, and the z-score of -1.2 shows options traders are slightly less defensive than their recent norm. Taken together, the positioning setup looks like a stock in a price correction, not a short-driven takedown.
The Street is pushing back hard against the price action. Morgan Stanley stepped in last week, with Matthew Cost assuming coverage and slapping an Overweight rating with a $230 target. Rosenblatt launched with a Buy and $245 target at the start of September. Both initiations came after the stock had already lost significant ground, which makes the timing notable. The broader analyst consensus is even more bullish — the mean price target from over a dozen recent actions is $239, implying roughly 45% upside from current levels. The factor scores reinforce this: analyst recommendation differential ranks in the 98th percentile of the ORTEX universe, a reading that reflects near-unanimous bullish coverage rather than a divided Street. Evercore raised its target to $270 after Q2 results in late August; UBS pushed to $274. These are not hedged, qualitative upgrades — they are large target increases from firms that had already been bullish. The bear case, such as it is, centres on US travel demand softening, European room-night growth missing guidance expectations for H2, and limited visibility into whether the company's 7% room-night growth target is achievable in the back half of the year.
Insider activity offers a mild caution flag, though the context matters. The 90-day net is a $17.2m outflow across several executives, including a chunky block of sales from the General Counsel in mid-August totalling close to $8.5m. Every single trade in the recent history is flagged as executing under a 10b5-1 pre-arranged plan, which strips most of the discretionary signal. These are scheduled liquidations, not conviction selling. Capital Research and Management was the most notable institutional mover in the last reported period, adding 8.2 million shares — a material addition for a manager of that size, and a data point that sits awkwardly alongside the stock's subsequent 20%-plus decline.
Peer performance adds colour. Expedia fell 4.2% on the week, Airbnb dropped 3.9%, and DoorDash shed 3.1% — suggesting the pressure on BKNG is not purely idiosyncratic and that the broader consumer-travel and discretionary-spending complex is under rotation pressure. MakeMyTrip was the standout exception, up 0.9% on the week, which may reflect its different geographic exposure.
Q3 earnings are on the calendar for October 29. That print will be the first real test of whether the H2 room-night guidance holds and whether the cost-transformation programme's margin gains can survive softer volume — two tensions the market will be watching closely against a consensus that is already priced for a significant re-rating higher.
See the live data behind this article on ORTEX.
Open BKNG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
